J&J Acquisition is to Strengthen Global Leadership in Eye Health Adding Cataract and Refractive Eye Surgery to Vision Care Portfolio. J&J will pay $4.325 billion in cash.
Abbott Medical Optics is a worldwide leader in ophthalmic surgery and is known for world-class intra-ocular lenses used in cataract surgery. The World Health Organization estimates that approximately 20 million people are blind from age-related cataracts and that there are at least 100 million eyes with compromised visual acuity caused by cataracts. These numbers are steadily rising due to population growth and increasing life expectancy.
Press release :
578 total views, 1 views today